Literature DB >> 19429912

Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation.

Meredith Downes1, Mathias François, Charles Ferguson, Robert G Parton, Peter Koopman.   

Abstract

Mutations in the transcription factor gene SOX18 cause vascular, lymphatic and hair follicle defects in humans with dominant and recessive forms of hypotrichosis-lymphedema-telangiectasia (HLT) syndrome. Here, we clarify the role of SOX18 in the vascular dysfunction in HLT by ultrastructural, immunofluorescence, molecular and functional analysis of vascular anomalies in embryos of the naturally occurring Sox18-mutant mouse strain ragged-opossum (Ra(Op)). Early genesis and patterning of vasculature was unimpaired in Ra(Op) embryos, but surface capillaries became enlarged from 12.5 dpc and embryos developed massive surface hemorrhage by 14.5 dpc. Large focal breaches in the endothelial barrier were observed, in addition to endothelial hyperplasia associated with impaired pericyte recruitment to the microvasculature. Expression of the genes encoding the endothelial factors MMP7, IL7R and N-cadherin was reduced in Ra(Op) embryos, suggesting that these are downstream targets of SOX18. Together, our results indicate that vascular anomalies in HLT arise from defects in regulation of genes required for the acquisition of structural integrity during microvascular maturation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429912     DOI: 10.1093/hmg/ddp219

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  Hyaluroan-regulated lymphatic permeability through S1P receptors is crucial for cancer metastasis.

Authors:  Mengsi Yu; Pingqing He; Yiwen Liu; Yiqing He; Yan Du; Man Wu; Guoliang Zhang; Cuixia Yang; Feng Gao
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

2.  Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.

Authors:  Bartosz Pula; Mateusz Olbromski; Andrzej Wojnar; Agnieszka Gomulkiewicz; Wojciech Witkiewicz; Maciej Ugorski; Piotr Dziegiel; Marzena Podhorska-Okolow
Journal:  Cell Oncol (Dordr)       Date:  2013-09-25       Impact factor: 6.730

3.  Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.

Authors:  A Mendola; M J Schlögel; A Ghalamkarpour; A Irrthum; H L Nguyen; E Fastré; A Bygum; C van der Vleuten; C Fagerberg; E Baselga; I Quere; J B Mulliken; L M Boon; P Brouillard; M Vikkula
Journal:  Mol Syndromol       Date:  2013-08-21

4.  A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity.

Authors:  Alex J McCann; Jieqiong Lou; Mehdi Moustaqil; Matthew S Graus; Ailisa Blum; Frank Fontaine; Hui Liu; Winnie Luu; Paulina Rudolffi-Soto; Peter Koopman; Emma Sierecki; Yann Gambin; Frédéric A Meunier; Zhe Liu; Elizabeth Hinde; Mathias Francois
Journal:  Nucleic Acids Res       Date:  2021-11-08       Impact factor: 16.971

5.  The transcription factor SOX18 regulates the expression of matrix metalloproteinase 7 and guidance molecules in human endothelial cells.

Authors:  Martina Hoeth; Heide Niederleithner; Renate Hofer-Warbinek; Martin Bilban; Herbert Mayer; Ulrike Resch; Christof Lemberger; Oswald Wagner; Erhard Hofer; Peter Petzelbauer; Rainer de Martin
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

6.  Tumor lymphangiogenesis as a potential therapeutic target.

Authors:  Tam Duong; Peter Koopman; Mathias Francois
Journal:  J Oncol       Date:  2012-02-16       Impact factor: 4.375

7.  Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina.

Authors:  Yulian Zhou; John Williams; Philip M Smallwood; Jeremy Nathans
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

8.  R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma.

Authors:  Jeroen Overman; Frank Fontaine; Jill Wylie-Sears; Mehdi Moustaqil; Lan Huang; Marie Meurer; Ivy Kim Chiang; Emmanuelle Lesieur; Jatin Patel; Johannes Zuegg; Eddy Pasquier; Emma Sierecki; Yann Gambin; Mohamed Hamdan; Kiarash Khosrotehrani; Gregor Andelfinger; Joyce Bischoff; Mathias Francois
Journal:  Elife       Date:  2019-07-30       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.